Redundant angiogenic signaling and tumor drug resistance

RN Gacche, YG Assaraf - Drug Resistance Updates, 2018 - Elsevier
Angiogenesis research in the past two decades has contributed significantly towards
understanding the molecular pathophysiology of cancer progression and inspired target …

[HTML][HTML] Unraveling the role of angiogenesis in cancer ecosystems

I Zuazo-Gaztelu, O Casanovas - Frontiers in Oncology, 2018 - frontiersin.org
Activation of the tumor and stromal cell-driven angiogenic program is one of the first
requirements in the tumor ecosystem for growth and dissemination. The understanding of …

Use of angiogenesis inhibitors in tumour treatment

J Fayette, JC Soria, JP Armand - European Journal of Cancer, 2005 - Elsevier
Advances in molecular biology have permitted the characterisation of mechanisms
underlying angiogenesis. Angiogenesis is a crucial process in tumour pathogenesis as it …

Tumor angiogenesis and anti-angiogenic strategies for cancer treatment

RI Teleanu, C Chircov, AM Grumezescu… - Journal of clinical …, 2019 - mdpi.com
Angiogenesis is the process through which novel blood vessels are formed from pre-existing
ones and it is involved in both physiological and pathological processes of the body …

Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth

RN Gacche, RJ Meshram - Progress in biophysics and molecular biology, 2013 - Elsevier
Angiogenesis: a process of generation of new blood vessels has been proved to be
necessary for sustained tumor growth and cancer progression. Inhibiting angiogenesis …

Angiogenesis in cancer-general pathways and their therapeutic implications

I Dimova, G Popivanov, VG Djonov - Jbuon, 2014 - boris.unibe.ch
A vast amount of data shows that angiogenesis has a pivotal role in tumor growth,
progression, invasiveness and metastasis. This is a complex process involving essential …

Growing tumor vessels: more than one way to skin a cat–implications for angiogenesis targeted cancer therapies

RL de Oliveira, A Hamm, M Mazzone - Molecular aspects of medicine, 2011 - Elsevier
The establishment of a functional, integrated vascular system is instrumental for tissue
growth and homeostasis. Without blood vessels no adequate nutrition and oxygen would be …

[HTML][HTML] Anti-angiogenic therapy in cancer: downsides and new pivots for precision medicine

G Lupo, N Caporarello, M Olivieri, M Cristaldi… - Frontiers in …, 2017 - frontiersin.org
Primary solid tumors originate close to pre-existing tissue vasculature, initially growing along
such tissue blood vessels, and this phenomenon is important for the metastatic potential …

Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?

C Sessa, A Guibal, G Del Conte… - Nature clinical practice …, 2008 - nature.com
Since 2004, four antiangiogenic drugs have been approved for clinical use in patients with
advanced solid cancers, on the basis of their capacity to improve survival in phase III clinical …

Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor

Y Zhao, AA Adjei - The oncologist, 2015 - academic.oup.com
Angiogenesis, or the formation of new capillary blood vessels, occurs primarily during
human development and reproduction; however, aberrant regulation of angiogenesis is also …